These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7901205)

  • 1. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor.
    Green SA; Cole G; Jacinto M; Innis M; Liggett SB
    J Biol Chem; 1993 Nov; 268(31):23116-21. PubMed ID: 7901205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
    Green SA; Holt BD; Liggett SB
    Mol Pharmacol; 1992 May; 41(5):889-93. PubMed ID: 1350321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation of the beta 2-adrenergic receptor impairs agonist activation of adenylyl cyclase without affecting high affinity agonist binding. Distinct molecular determinants of the receptor are involved in physical coupling to and functional activation of Gs.
    Hausdorff WP; Hnatowich M; O'Dowd BF; Caron MG; Lefkowitz RJ
    J Biol Chem; 1990 Jan; 265(3):1388-93. PubMed ID: 2153131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupling of a mutated form of the human beta 2-adrenergic receptor to Gi and Gs. Requirement for multiple cytoplasmic domains in the coupling process.
    Liggett SB; Caron MG; Lefkowitz RJ; Hnatowich M
    J Biol Chem; 1991 Mar; 266(8):4816-21. PubMed ID: 1848226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor.
    Mason DA; Moore JD; Green SA; Liggett SB
    J Biol Chem; 1999 Apr; 274(18):12670-4. PubMed ID: 10212248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase.
    Fraser CM; Chung FZ; Wang CD; Venter JC
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5478-82. PubMed ID: 2840663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of tyrosine-350 impairs the coupling of the beta 2-adrenergic receptor to the stimulatory guanine nucleotide binding protein without interfering with receptor down-regulation.
    Valiquette M; Bonin H; Bouvier M
    Biochemistry; 1993 May; 32(19):4979-85. PubMed ID: 8388251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered phosphorylation and desensitization patterns of a human beta 2-adrenergic receptor lacking the palmitoylated Cys341.
    Moffett S; Mouillac B; Bonin H; Bouvier M
    EMBO J; 1993 Jan; 12(1):349-56. PubMed ID: 8381352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor.
    O'Dowd BF; Hnatowich M; Caron MG; Lefkowitz RJ; Bouvier M
    J Biol Chem; 1989 May; 264(13):7564-9. PubMed ID: 2540197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
    Suzuki T; Nguyen CT; Nantel F; Bonin H; Valiquette M; Frielle T; Bouvier M
    Mol Pharmacol; 1992 Mar; 41(3):542-8. PubMed ID: 1347641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-directed mutagenesis and continuous expression of human beta-adrenergic receptors. Identification of a conserved aspartate residue involved in agonist binding and receptor activation.
    Chung FZ; Wang CD; Potter PC; Venter JC; Fraser CM
    J Biol Chem; 1988 Mar; 263(9):4052-5. PubMed ID: 2831218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A match between binding to beta-adrenoceptors and stimulation of adenylyl cyclase parameters of (-)isoproterenol and salbutamol on rat brain.
    Garnier V; Zini R; Sapena R; Tillement JP
    Pharmacol Res; 1997 Apr; 35(4):303-12. PubMed ID: 9264046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).
    Green SA; Rathz DA; Schuster AJ; Liggett SB
    Eur J Pharmacol; 2001 Jun; 421(3):141-7. PubMed ID: 11516429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005.
    Kikkawa H; Isogaya M; Nagao T; Kurose H
    Mol Pharmacol; 1998 Jan; 53(1):128-34. PubMed ID: 9443940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
    Zhu SJ; Toews ML
    Mol Pharmacol; 1994 Feb; 45(2):255-61. PubMed ID: 7906855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the uncoupling protein gene (Ucp) by beta 1, beta 2, and beta 3-adrenergic receptor subtypes in immortalized brown adipose cell lines.
    Rohlfs EM; Daniel KW; Premont RT; Kozak LP; Collins S
    J Biol Chem; 1995 May; 270(18):10723-32. PubMed ID: 7738011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-binding-activity analysis of beta-adrenergic amines--I. Binding to the beta receptor and activation of adenylate cyclase.
    Bilezikian JP; Dornfeld AM; Gammon DE
    Biochem Pharmacol; 1978 May; 27(10):1445-54. PubMed ID: 29638
    [No Abstract]   [Full Text] [Related]  

  • 18. Examination of the effects of increasing Gs protein on beta2-adrenergic receptor, Gs, and adenylyl cyclase interactions.
    Krumins AM; Barber R
    Biochem Pharmacol; 1997 Jul; 54(1):61-72. PubMed ID: 9296351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid substitution in the beta-adrenergic receptor promotes partial agonist activity from antagonists.
    Strader CD; Candelore MR; Hill WS; Dixon RA; Sigal IS
    J Biol Chem; 1989 Oct; 264(28):16470-7. PubMed ID: 2570781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.
    Green SA; Turki J; Innis M; Liggett SB
    Biochemistry; 1994 Aug; 33(32):9414-9. PubMed ID: 7915137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.